A Gray Zone Approach to Stroke Volume Variation Derived From NICOM

May 26, 2016 updated by: Jong Hwan Lee, Samsung Medical Center

Evaluation of Stroke Volume Variation Derived From NICOM as a Predictor of Fluid Responsiveness in Neurosurgical Patients: A Gray Zone Approach

Optimal fluid management has been considered as crucial part to determine postoperative outcome and organ function. Recently developed, non invasive cardiac output measurement(NICOM, Cheetah Medical, Portland, OR)has enabled continuous cardiac output(CO) monitoring just by attaching electrode on chest wall. Moreover, CO and SSV derived from NICOM have been demonstrated as predictors of fluid responsiveness. Therefore, the aim of this study is to evaluate stroke volume variation derived from NICOM as a predictor of fluid responsiveness in neurosurgical patients. In addition, we plan to reveal inconclusive patients using gray zone approach.

Study Overview

Detailed Description

Optimal fluid management has been considered as crucial part to determine postoperative outcome and organ function. Many reports have focussed on evaluation of fluid responsiveness using various parameters such as pulse pressure variation (PPV) or stroke volume variation (SSV) derived from invasive or semi-invasive monitoring. Recently developed, non invasive cardiac output measurement(NICOM, Cheetah Medical, Portland, OR)has enabled continuous cardiac output(CO) monitoring just by attaching electrode on thorax. Moreover, CO and SSV derived from NICOM have been demonstrated as predictors of fluid responsiveness. Therefore, the aim of this study is to evaluate stroke volume variation derived from NICOM as a predictor of fluid responsiveness in neurosurgical patients. In addition, we plan to reveal inconclusive patients using gray zone approach.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients undergoing neurosurgery under general anesthesia in supine position

Description

Inclusion Criteria:

  • ASA I or ASA II patients aged 20-80 undergoing neurosurgery in supine position

Exclusion Criteria:

  • Pre-existing arrythmic disorders
  • Congestive heart failure required medical treatment
  • Preoperative Creatinine 1.3mg/dl
  • observing self respiration during the study interventions
  • Bleeding tendency
  • Severe brain edema

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
500ml fluid loading
All enrolled patients
Fluid loading to evaluate fluid responsiveness
Other Names:
  • 500ml loading of crystalloid(Plasma Solution-A Injection CJ) over 15min
  • at the end of operation, when the main procedure finished and there is no strong
  • stimulation with stable hemodynamics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke volume variation
Time Frame: 5min following the end of rapid fluid infusion
5min following the end of rapid fluid infusion: 5 min after the end of fluid loading
5min following the end of rapid fluid infusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation with pulse pressure variation
Time Frame: 5 min following the end of rapid fluid infusion
5min following the end of rapid fluid infusion: 5 min after the end of fluid loading
5 min following the end of rapid fluid infusion

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
TPR(total peripheral resistance), TPRI(total peripheral resistance index)
Time Frame: 5min following the end of rapid fluid infusion
5min following the end of rapid fluid infusion: 5 min after the end of fluid loading
5min following the end of rapid fluid infusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jong-Hwan Lee, MD, PhD, Samsung Medical Center, Sungkyunkwan University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Anticipated)

January 1, 2014

Study Completion (Anticipated)

May 1, 2014

Study Registration Dates

First Submitted

June 28, 2013

First Submitted That Met QC Criteria

July 10, 2013

First Posted (Estimate)

July 15, 2013

Study Record Updates

Last Update Posted (Estimate)

May 27, 2016

Last Update Submitted That Met QC Criteria

May 26, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fluid Responsiveness

Clinical Trials on 500ml fluid loading

3
Subscribe